Your browser doesn't support javascript.
loading
First Total-Body Kinetic Modeling and Parametric Imaging of Dynamic 68Ga-FAPI-04 PET in Pancreatic and Gastric Cancer.
Chen, Ruohua; Yang, Xinlan; Ng, Yee Ling; Yu, Xiaofeng; Huo, Yanmiao; Xiao, Xiuying; Zhang, Chenpeng; Chen, Yumei; Zheng, Chaojie; Li, Lianghua; Huang, Gang; Zhou, Yun; Liu, Jianjun.
Afiliación
  • Chen R; Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Yang X; Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Ng YL; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Yu X; Central Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai, China.
  • Huo Y; Central Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai, China.
  • Xiao X; Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang C; Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Chen Y; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Zheng C; Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and.
  • Li L; Department of Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Huang G; Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhou Y; Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Liu J; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.
J Nucl Med ; 64(6): 960-967, 2023 06.
Article en En | MEDLINE | ID: mdl-36604180
ABSTRACT
Fibroblast activation protein inhibitor (FAPI) is an ideal diagnostic and therapeutic target in malignant tumors. However, the knowledge of kinetic modeling and parametric imaging of 68Ga-FAPI is limited.

Purpose:

The purpose of this study was to explore the pharmacokinetics of 68Ga-FAPI-04 PET/CT in pancreatic cancer and gastric cancer and to conduct parametric imaging of dynamic total-body data compared with SUV imaging.

Methods:

Dynamic total-body 68Ga-FAPI-04 PET/CT was performed on 13 patients. The lesion time-activity curves were fitted by 3-compartment models and multigraphical models. The kinetics parameters derived from the 2-tissue reversible compartment model (2T4K) and multigraphical models were analyzed. Parametric [Formula see text] imaging was generated using the 2T4K and Logan models, and their performances were evaluated compared with SUV images.

Results:

2T4K had the lowest Akaike information criterion value, and its fitting curves matched excellently with the origin time-activity curves. Visual assessment revealed that the [Formula see text](2T4K) images and [Formula see text](Logan with spatial constraint [SC]) images both showed less image noise and higher lesion conspicuity compared with SUV images. Objective image quality assessment demonstrated that parametric [Formula see text](2T4K) images and parametric [Formula see text](Logan with SC) images had a 5.0-fold and 5.0-fold higher average signal-to-noise ratio and 3.6-fold and 4.1-fold higher average contrast-to-noise ratio compared with conventional SUV images, respectively. In addition, no significant differences in signal-to-noise ratio and contrast-to-noise of pathologic lesions were observed between parametric [Formula see text](2T4K) images and parametric [Formula see text](Logan with SC) images (all P > 0.05).

Conclusions:

The 2T4K model was the preferred compartment model. Total-body parametric imaging of 68Ga-FAPI-04 PET yielded superior quantification beyond SUV with enhanced lesion contrast, which may serve as a promising imaging method to make an early diagnosis, to better reflect tumor characterization, or to allow evaluation of treatment response. [Formula see text](2T4K) images are comparable in image quality and consistent to [Formula see text](Logan with SC) images in lesions conspicuity; however, [Formula see text](Logan with SC) images presented an appealing alternative to [Formula see text](2T4K) images because of their simplicity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: J Nucl Med Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: J Nucl Med Año: 2023 Tipo del documento: Article País de afiliación: China